Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 27, 2015 5:17 PM ET

Biotechnology

Company Overview of Paratek Pharmaceuticals, Inc.

Company Overview

Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines to save lives and alleviate suffering. Its lead product candidate, omadacycline, is a tetracycline-derived, broad-spectrum antibiotic being developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections. The company has special protocol assessment agreements with The Food and Drug Administration (FDA) for the Phase III trials planned in ABSSSI and CABP. Its o...

75 Kneeland Street

Boston, MA 02111

United States

12 Employees

Phone:

617-275-0040

Key Executives for Paratek Pharmaceuticals, Inc.

President, Chief Medical Officer and Director
Age: 55
Total Annual Compensation: $291.1K
Chief Compliance Officer, Vice President of Administration and General Counsel
Age: 45
Total Annual Compensation: $265.9K
Vice President of Research and Development
Age: 62
Total Annual Compensation: $226.0K
Compensation as of Fiscal Year 2013.

Paratek Pharmaceuticals, Inc. Key Developments

Paratek Pharmaceuticals, Inc. Presents at Jefferies 2015 Antibiotic Summit, Mar-18-2015

Paratek Pharmaceuticals, Inc. Presents at Jefferies 2015 Antibiotic Summit, Mar-18-2015 . Venue: New York City, New York, United States. Speakers: Evan Loh, President, Chief Medical Officer and Director.

Paratek Pharmaceuticals, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:00 PM

Paratek Pharmaceuticals, Inc. Presents at BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference, Mar-20-2015 02:00 PM. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Speakers: Michael F. Bigham, Chairman of the Board and Chief Executive Officer.

Paratek Pharmaceuticals, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 04:10 PM

Paratek Pharmaceuticals, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 04:10 PM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: Michael F. Bigham, Chairman of the Board and Chief Executive Officer.

Similar Private Companies By Industry

Company Name Region
Phage Biotechnology Corporation United States
UroVention, LLC United States
AMBA Biosciences, LLC United States
Kemp Biotechnologies Inc. United States
Edwards Lifesciences Cardiovascular Resources Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
July 1, 2014
Transcept Pharmaceuticals, Inc.
Private Placement
June 30, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Paratek Pharmaceuticals, Inc., please visit www.paratekpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.